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Abstract
Background: Circulating thiobarbituric acid-reacting substance (TBARS) levels, a marker of systemic oxidative stress,
are predictive of cardiovascular events. However, they has not been evaluated in Japanese, especially with regard
to the factors that contribute to the changes in circulating TBARS levels. We investigated the cross-sectional and
longitudinal relationships between circulating TBARS levels and various clinicobiochemical parameters in middle-
aged men.
Methods: In this population-based study (The Amagasaki Visceral Fat Study), 1,178 Japanese male urban workers
who had undergone health check-ups in 2006, 2007 and 2008 and were not on medications for metabolic
disorders during the follow-up period, were enrolled. Serum TBARS levels were measured by the method of Yagi.
The estimated visceral fat area (eVFA) by bioelectrical impedance was measured annually. After health check-ups,
subjects received health education with lifestyle modification by medical personnel.
Results: The number of cardiovascular risk factors (hypertension, hyperglycemia, low HDL-C, hypertriglyceridemia,
hyperuricemia, hyper-LDL-C and impaired renal function) augmented with the increases in log-eVFA (p < 0.0001) and
log-TBARS (p < 0.0001). The combination of TBARS and eVFA had a multiplicative effect on risk factor accumulation (F
value = 79.1, p = 0.0065). Stepwise multiple regression analysis identified log-eVFA, as well as age, log-body mass
index (BMI), LDL-C, log-adiponectin, g-glutamyl transpeptidase (g-GTP) and uric acid as significant determinants of log-
TBARS. Stepwise multiple regression analysis identified one-year changes in eVFA as well as BMI, g-GTP and estimated
glomerular filtration rate (eGFR) as significant determinants of one-year change in TBARS, and biennial changes in
eVFA as well as BMI and g-GTP, eGFR as significant determinants of biennial change in TBARS.
Conclusions: The present study showed a significant cross-sectional and longitudinal correlation between TBARS
and eVFA, as well as BMI and g- GTP, eGFR. Visceral fat reduction may independently associate with the
improvement in systemic ROS in middle-aged Japanese men.
Trial Registration: The Amagasaki Visceral Fat Study UMIN000002391.
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Oxidative stress results from an imbalance between reac-
tive oxygen species (ROS) and antioxidants, and is influ-
enced by genetic and environmental factors. In the
general population, serum levels of thiobarbituric acid-
reacting substance (TBARS), an important biomarker of
systemic oxidative stress, were reported to be associated
with various factors, such as age, body mass index (BMI),
glucose metabolism, lipid metabolism [1], g-glutamyl
transpeptidas (g-GTP) [2], uric acid (UA) [3] and smok-
ing, and the levels correlated with atherosclerogenesis [4].
Serum levels of TBARS were strongly predictive of cardi-
ovascular events in patients with stable coronary artery
disease, independently of traditional risk factors [5,6].
We reported previously that adipose tissue is the
major source of ROS (called FatROS), and that systemic
oxidative stress is closely associated with fat accumula-
tion in obese animals [7]. These animals also exhibited
selective overproduction of ROS in adipose tissue, as
well as over-expression of NADPH oxidase and under-
expression of antioxidative enzymes [7]. We and others
have demonstrated that increased FatROS and systemic
oxidative stress are the underlying causes of dysregu-
lated production of adipocytokines (e.g., hypoadiponecti-
nemia and high levels of plasminogen activator
inhibitor-1, interleukin-6, and monocyte chemoattrac-
tant protein-1), which might lead to the development of
lifestyle-related diseases [7,8]. In obese mice, treatment
with NADPH oxidase inhibitors reduced ROS produc-
tion by the adipose tissue, attenuated the dysregulation
of adipocytokines, and improved diabetes and hyperlipi-
demia [7]. However, the level of systemic ROS produc-
tion has not been evaluated properly in the general
population, especially with regard to the factors that
contribute to the changes in systemic ROS production.
The present cross-sectional and longitudinal study
investigated the relationship between circulating TBARS
levels and various clinicobiochemical parameters in mid-
dle-aged Japanese male urban workers.
Methods and Procedures
Participants
The study subjects were 1,178 Japanese men [age; mean
± SD 45 ± 10 (range, 20-68) years], who were employees
of the Amagasaki city office and had undergone annual
health check-ups in three consecutive years (2006, 2007
and 2008). To avoid the influence of medications, we
excluded subjects who were on treatment for diabetes,
hypertension and dyslipidemia during the 2-year follow-
up period. Table 1 left summarizes the profiles of all
participants at baseline. After the health check-up, the
medical staff, especially health nurses, provided the indi-
vidual with annual health promotion program to
promote voluntary lifestyle changes (2006 and 2007) [9].
In brief, the program emphasized hazards of visceral fat
accumulation and multiple cardiovascular risk factors,
with the aim of encouraging a scientific understanding
of the concept of metabolic syndrome from visceral fat
accumulation to the development of atherosclerotic car-
diovascular diseases. We reported previously that this
program should be useful in reducing visceral fat accu-
mulation and consequently decrease number of cardio-
vascular risks, such as glucose tolerance, dyslipidemia,
high blood pressure [10], hypoadiponectinemia [11], and
a prevalence of the metabolic syndrome [9], leading to
prevention of cardiovascular events [12,13].
Anthropometry and laboratory measurements
Body weight (kg), height (cm), and waist circumference
at umbilical level (cm) were measured in standing posi-
tion, and systolic and diastolic blood pressures (SBP,
DBP, respectively) were measured with a standard mer-
cury sphygmomanometer after rest in sitting position
for at least 5 minutes. BMI was calculated using the for-
mula [weight (kg)/height (m)
2]. Visceral fat area was
estimated by bioelectrical impedance analysis (eVFA), as
we reported previously [14]. After overnight fasting or
at least 5 hours-fasting, venous blood samples were col-
lected for measurements of blood glucose (BS), hemo-
globin A1c (HbA1c, National Glycohemoglobin
Standardization Program), triglyceride (TG), high-den-
sity lipoprotein-cholesterol (HDL-C), high-density lipo-
protein-cholesterol (LDL-C), g-glutamyl transpeptidase
(g-GTP), creatinine, uric acid (UA) and adiponectin
(Otsuka Pharmaceutical Co., Tokushima, Japan), while
the subject was in sitting position. For the purpose of
the present study, serum samples that were obtained at
baseline from each participant and stored promptly at
-20°C without the addition of exogenous antioxidants
before TBARS assay. After thawing the samples, serum
levels of malondialdehyde in terms of TBARS, a marker
of systemic ROS production, were measured in duplicate
in each of 3,534 samples by the method of Yagi (Japan
Institute for the Control of Aging, Nikken SEIL Co., Shi-
zuoka, Japan) [15], as we [16,17] and other [18] pre-
viously reported. The selection of this parameter was
based on the fact that malondialdehyde can be gener-
ated from oxidative mechanisms other than lipid peroxi-
dation, and that TBARS is assumed to represent a
composite of systemic oxidative damage products,
including malondialdehyde [18]. Glomerular filtration
rate was estimated by the following equation (eGFR =
194 × serum creatinine
-1.094 × age
-0.287).
We investigated the presence of seven cardiovascular
risk factors: 1) hypertension (SBP ≥ 130 and/or DBP ≥ 80
mmHg) [19], 2) hyperglycemia (fasting or postprandial
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HDL-C (HDL-C < 1.04 mmol/L) [19], 4) hypertriglyceri-
demia (fasting or postprandial TG of ≥ 1.69 or 2.27
mmol/L, respectively) [19], 5) hyperuricemia (UA ≥ 416
μmol/L), 6) hyper-LDL-cholesterolemia (LDL-C ≥ 3.64
mmol/L) and 7) impaired renal function (eGFR < 60 mL/
min/1.73 m
2).
Statistical analysis
Data of TBARS, eVFA and adiponectin levels showed
skewed distribution, and were thus log-transformed
before analysis. Pearson’s correlation coefficient was
used to examine the relationship between log-TBARS
and various clinicometabolic parameters, and between
one-year and biennial changes in TBARS and various
clinicometabolic parameters. Significant level was set at
p < 0.05. Stepwise multiple regression analysis was con-
ducted to identify the parameters that significantly con-
tributed to log-TBARS or one-year and biennial changes
in TBARS. Parameters with F value > 4.0 were subse-
quently entered into regression analysis as independent
variables. Differences in the mean number of obesity-
related cardiovascular risk factors between eVFA and
TBARS were analyzed by the Kruskal-Wallis test (Figure
1). Differences among groups were compared by
unpaired Student’s t-test for experiments involving only
two groups (Figure 2). Continuous variables were
expressed as mean ± SEM (Figure 2) or SD (Table 1).
All statistical analyses were performed with the Statisti-
cal Package for Social Sciences (vesion 11.0.1J; SPSS,
Chicago, IL).
Ethics Approval
The study was approved by the human ethics committee
of Osaka University and a signed informed consent was
obtained from each participant, based on the ethical
guideline of the 2000 Declaration of Helsinki of the
World Medical Association.
Results
The cross-sectional study
First, we compared the mean number of cardiovascular
risk factors (hypertension, hyperglycemia, low HDL-C,
hypertriglyceridemia, hyperuricemia, hyper-LDL-C and
impaired renal function) after classifying the subjects
according to the log-eVFA and log-TBARS values. The
number of risk factors increased significantly with the
increase in eVFA (p < 0.0001 for trend, the Kruskal-
Wallis test). Moreover, the number of cardiovascular
risk factors increased significantly with increased levels
of circulating TBARS (p < 0.0001 for trend, the Kruskal-
Wallis test) (Figure 1). We investigated the supra-
Table 1 Baseline characteristics of the studied population (n = 1,178)
year 2006 (n = 1,178) year 2007 (n = 1,178) year 2008 (n = 1,178)
Age (year) 45 ± 10 (20-68) 46 ± 10 (21-69) 47 ± 10 (22-70)
Body weight (kg) 68.8 ± 9.5 (43.7-118.5) 68.8 ± 9.6 (44.4-124.5) 68.7 ± 9.7 (44.0-118.1)
Body mass index (kg/m
2) 23.8 ± 2.9 (16.4-37.6) 23.8 ± 3.0 (15.9-39.4) 23.8 ± 3.0 (16.0-37.1)
Waist circumference (cm) 82.5 ± 8.1 (59-119) 82.5 ± 8.2 (60-117) 81.9 ± 8.0 (59-119)
Estimated visceral fat area (cm
2) 88.5 ± 38.5 (14-304) 89.8 ± 39.3 (4-290) 87.8 ± 37.8 (4-316)
Systolic blood pressure (mmHg) 123 ± 14 (86-174) 122 ± 15 (90-186) 122 ± 16 (87-190)
Diastolic blood pressure (mmHg) 75 ± 10 (45-120) 75 ± 11 (46-110) 75 ± 11 (51-116)
Total cholesterol (mmol/L) 5.17 ± 0.85 (2.6-8.7) 5.20 ± 0.86 (2.8-8.5) 5.19 ± 0.85 (2.5-8.6)
Triglyceride (mmol/L) 1.61 ± 1.36 (0.25-23.8) 1.65 ± 1.21 (0.24-10.6) 1.62 ± 1.25 (0.24-16.8)
High-density lipoprotein-cholesterol (mmol/L) 1.43 ± 0.34 (0.62-2.75) 1.50 ± 0.38 (0.57-3.39) 1.50 ± 0.39 (0.39-2.93)
Low-density lipoprotein-cholesterol (mmol/L) 3.00 ± 0.75 (0.93-6.14) 3.23 ± 0.80 (0.91-6.68) 3.12 ± 0.78 (0.67-5.88)
Hemoglobin A1c (%), JDS 5.1 ± 0.6 (3.0-10.8) 5.1 ± 0.5 (3.5-10.2) 5.2 ± 0.5 (3.3-9.9)
g-GTP (μkat/L) 0.48 ± 0.55 (0.10-6.30) 0.47 ± 0.57 (0.08-8.85) 0.49 ± 0.63 (0.09-6.81)
Creatinine (μmol/L) 77.8 ± 9.8 (49.5-116.7) 75.8 ± 10.1 (43.3-113.2) 75.4 ± 10.0 (48.6-116.7)
eGFR (mL/min/1.73 m
2) 77.0 ± 11.8 (44.6-124.9) 78.8 ± 12.5 (46.6-135.5) 78.8 ± 12.6 (47.7-138.0)
Uric acid (mmol/L) 362.0 ± 71.8 (136.8-618.6) 361.0 ± 72.6 (124.9-672.2) 360.5 ± 70.3 (124.9-636.5)
TBARS (nmol/mL) 7.6 ± 2.3 (3.0-20.1) 7.7 ± 2.0 (3.7-25.3) 5.9 ± 1.6 (2.8-18.7)
Adiponectin (μg/mL) 6.7 ± 3.1 (0.8-31.8) 7.0 ± 3.3 (0.7-37.3) 7.3 ± 3.7 (0.6-39.1)
Smoking
Current-smoker n = 460 39.0% n = 442 37.5% n = 366 31.1%
Ex-smoker n = 172 14.6% n = 186 15.8% n = 170 14.4%
Non-smoker n = 546 46.4% n = 550 46.7% n = 642 54.5%
Data are mean ± SD (range) or numbers (n) of subjects.
g-glutamyl transpeptidase (g-GTP), eGFR; estimated glomerular filtration rate, TBARS; thiobarbituric acid reactive substances.
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risk factor accumulation using age-adjusted multiplica-
tive interaction term (log TBARS × log eVFA) in the
linear regression model, and log TBARS and log-eVFA
individually. Multiple linear regression analysis (adopted
factors; age, log TBARS, log-eVFA, log TBARS × log
eVFA) identified interaction term (log TBARS × log
eVFA) as a significant determinant of cardiovascular risk
factor accumulation (F value = 79.1, p = 0.0065). These
results indicated that the combination of TBARS and
eVFA had a multiplicative effect on cardiovascular risk
factor accumulation (Figure 1).
Second, analysis of data collected in year 2006 showed
positive relationships between log-TBARS and the fol-
l o w i n gp a r a m e t e r s :a g e ,B M I ,w a i s tc i r c u m f e r e n c e ,l o g -
e V F A ,S B P ,D B P ,L D L - C ,H b A 1 c ,g-GTP, ex-/current-
smoking and UA, and a negative relationship between
log-TBARS and log-adiponectin and eGFR (Table 2).
Stepwise multiple regression analysis identified age,
LDL-C, log adiponectin, g-GTP, UA and log-eVFA
[multivariate 1 (eVFA); adopted factors: age, eVFA SBP,
LDL-C, HbA1c, log-adiponectin, g-GTP, eGFR, UA,
smoking status] or log-BMI [multivariate 2 (BMI);
adopted factors; age, BMI SBP, LDL-C, HbA1c, log-adi-
ponectin, g-GTP, eGFR, UA, smoking status], as signifi-
cant determinants of log-TBARS (Table 2).
Next, to clarify whether the degree of obesity or body
fat distribution relates more strongly with circulating
TBARS levels, we divided subjects into four groups
according to BMI (cutoff value 25 kg/m
2)a n de V F A
(cutoff value 100 cm
2), based on Japanese criteria of
obesity and visceral fat accumulation [20] (Figure 2).
Subjects with eVFA ≥ 100 cm
2 had significantly higher
levels of circulating TBARS than those with eVFA
<100 cm
2, irrespective of BMI (p < 0.0001, respec-
tively). Interestingly, subjects with visceral fat accumu-
lation but without overall obesity (eVFA ≥ 100 cm
2
plus BMI < 25 kg/m
2) had significantly higher levels of
circulating TBARS than those without visceral fat accu-
mulation but with overall obesity (eVFA <100 cm
2 plus
BMI ≥ 25 kg/m
2) (p = 0.026). These results indicate
that body fat distribution, rather than with the degree
of obesity, should be more associated with circulating
TBARS levels.
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Figure 1 Mean number of cardiovascular risk factors in the study population in relation to the log estimated visceral fat area (log-
eVFA) and log-circulating thiobarbituric acid-reacting substance levels (log-TBARS). Each parameter was categorized into quartiles (Q1-Q4).
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We also investigated the relationship between one-year
changes in TBARS (one-year ΔTBARS) and various
parameters (Table 3A). The one-year ΔTBARS corre-
lated positively with one-year ΔBMI, ΔeVFA, Δg-GTP,
ΔeGFR, and ΔUA. Stepwise multiple regression analysis
identified one-year Δg-GTP, ΔeGFR, log-eVFA [multi-
variate 1 (one-year ΔeVFA); adopted factors; one-year
ΔeVFA, Δg-GTP, ΔeGFR, ΔUA] and log-BMI [multivari-
ate 2 (one-year ΔBMI); adopted factors; one-year ΔBMI,
Δg-GTP, ΔeGFR, ΔUA] as significant determinants of
one-year ΔTBARS.
Moreover, we also investigated the relationships
between biennial changes in TBARS (biennial ΔTBARS)
and various parameters (Table 3B). Biennial ΔTBARS
correlated with biennial ΔBMI, Δwaist circumference,
ΔeVFA, ΔLDL-C, Δg-GTP, ΔeGFR, and ΔUA. Stepwise
multiple regression analysis identified biennial Δg-GTP,
ΔeGFR, log-eVFA [multivariate 1 (biennial ΔeVFA);
adopted factors; biennial ΔeVFA, ΔLDL-C, Δg-GTP,
ΔeGFR, ΔUA] and log-BMI [multivariate 2 (biennial
DBMI); adopted factors; biennial ΔBMI, ΔLDL-C, Δg-
GTP, ΔeGFR, ΔUA], as significant determinants of bien-
nial ΔTBARS (Table 3B).
Discussion
The cross-sectional study is the first to report that body
fat distribution, i.e. visceral fat accumulation, as well as
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Figure 2 Relationship between circulating TBARS levels and body fat distribution. Subjects were divided according to body mass index
(BMI) using a cutoff value of 25 kg/m
2 and estimated visceral fat area (eVFA) using a cutoff value of 100 cm
2, measured in 2006. Data are mean
± SEM. TBARS: thiobarbituric acid-reacting substance.
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Page 5 of 9age, BMI, LDL-C, g-GTP and UA as reported previously
[1-3], is important determinant of circulating TBARS
levels in Japanese men (Table 2). Moreover, subjects
with visceral fat accumulation had significantly higher
levels of circulating TBARS than those without visceral
fat accumulation, both in those with and without overall
obesity (Figure 2), as previous report demonstrated that
visceral fat thickness and serum TBARS levels [21]. The
results also emphasize the importance of visceral adi-
pose tissue per se as the major source of ROS in the
whole body in the general population, as we reported
previously in obese subjects [7] and in subjects at high
risk for cardiovascular diseases [22]. This present study
demonstrated that visceral fat may be the major source
of systemic oxidative stress, and that visceral fat accu-
mulation increased systemic oxidative stress with the
underlying causes of cardiovascular risk factor accumu-
lation (Figure 1) and dysregulated production of adipo-
cytokines (e.g., hypoadiponectinemia) (Table 2), which
might lead to the development of lifestyle-related disease
including coronary artery disease.
Another aim of the present study was to clarify
whether reduction of visceral fat associated with reduc-
tions in systemic oxidative stress. We reported pre-
viously that visceral fat reduction through lifestyle
modification reduced the number of atherosclerotic car-
diovascular events [12]. The present longitudinal study
indicated that weight loss and reduction of visceral fat
per se through lifestyle modification was associated with
reductions in systemic oxidative stress (Table 3) accom-
panied by improvement in cardiovascular risk accumula-
tion, which probably lessens the risk of atherosclerotic
cardiovascular diseases. Life-style modification designed
to effectively reduce the amount of visceral fat, which is
associated with improvement in liver and renal dysfunc-
tion, is probably beneficial in reducing systemic ROS
overload, leading to combat cardiovascular disease
events in human. There is no doubt that other factors
also influence the status of systemic oxidative stress,
such as physical activity, alcohol consumption, socio-
economic status, sleep status, psychogenic stress status
and dietary habits. These lifestyle changes themselves
may also reduce circulating TBARS levels, although
these effects were not analyzed in the present study.
The present study also showed a significant cross-sec-
tional and longitudinal correlation between TBARS and
markers of both liver and renal functions; g-GTP and
eGFR, respectively. g-GTP is the enzyme responsible for
extracellular catabolism of glutathione [2], and it has
been used as a marker of excessive alcohol intake or of
hepatic diseases [2]. g-GTP, as a scavenger of oxygen
free radicals, plays a key role in rather protecting against
both intracellular and extracellular oxidative stress [23].
However, many epidemiological studies have suggested
that increased g- G T Pl e v e l sm a yb eap r e c o c i o u sa n d
sensitive marker of oxidative stress, identifying persons
Table 2 Cross-sectional results of correlation between log-TBARS and various parameters by uni- and multi-variate
analyses
Log-TBARS Univariate Multivariate1 (eVFA) Multivariate2 (BMI)
r p value F value r p value F value r p value
Age 0.282 < 0.0001 55.452 0.203 < 0.0001 76.055 0.231 < 0.0001
BMI 0.211 < 0.0001 - - - 9.681 0.086 0.0012
WC 0.257 < 0.0001 - - - - - -
Log-eVFA 0.307 < 0.0001 15.023 0.115 0.0001 - - -
SBP 0.147 < 0.0001 0.066 - - 0.026 - -
DBP 0.212 < 0.0001 - - - - - -
HDL-C -0.050 0.0855 - - -
LDL-C 0.262 < 0.0001 45.483 0.184 < 0.0001 48.025 0.189 < 0.0001
HbA1c 0.156 < 0.0001 1.734 - - 1.587 - -
Log-adiponectin -0.190 < 0.0001 10.317 -0.089 0.0014 13.885 -0.101 0.0022
g-GTP 0.253 < 0.0001 34.293 0.163 < 0.0001 37.444 0.170 < 0.0001
eGFR -0.149 < 0.0001 0.078 - - 0.000 - -
UA 0.213 < 0.0001 16.529 0.112 < 0.0001 16.493 0.120 < 0.0001
Smoking (Current-) - 0.1235
Smoking (Ex- and Current-) - 0.0159 0.0002 - - 0.011 - -
Univariate: Pearson’s correlation analysis, Multivariate: Stepwise multiple regression analysis.
Parameters with F value > 4.0 were subsequently entered into the regression analysis as independent variables.
BW: Body weight, BMI: body mass index, WC: waist circumference, Log-eVFA: estimated visceral fat area,
SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL-C: high-density lipoprotein-cholesterol,
LDL-C: low-density lipoprotein-cholesterol, HbA1c: Hemoglobin A1c, eGFR: estimated glomerular filtration rate,
UA: uric acid.
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fatty liver disease [24]. Serum TBARS levels are elevated
in chronic kidney disease patients [25,26]. TBARS inter-
feres with nitric oxide generation through competitive
inhibition of nitric oxide (NO)-synthase enzyme, and
therefore may lead to impairent in endothelium NO
pathway in kidney [25-27]. Endothelial dysfunction is a
common event described both in chronic and acute
renal failure [27]. A possible direct association between
TBARS and g-GTP or eGFR should be examined by
further experimental studies.
Our study has several limitations. First, the results
may not be applicable to females or non-Japanese popu-
lations. Second, blood samples were collected at random
rather than at fixed daytime. Multiple measurements on
a like-for-like basis should be preformed for better
assessment of TBARS. Third, during the 2-year follow-
up (from 2006 to 2008), there was only one first-ever
cardiovascular disease event. Monitoring the long-term
effects of visceral fat reduction with lifestyle
modification on the cumulative incidence of cardiovas-
cular events is required. It is required to clarify the
effects of the health promotion program on compliance
and response and their potential influence on circulating
TBARS. Further controlled studies of blind and rando-
mized design should be also required. Fourth, smoking
status was collected through a self-questionnaireis (non-
, ex- or current-) without Brinkman index (daily number
of cigarettes × years). Therefore, the present study could
not investigate longitudinal study for smoking with
reliability. Fifth, the current study did not include the
effects of other important determinants of oxidative sta-
tus, such as physical activity, alcohol consumption,
smoking habits, socio-economic status, marital status,
sleep status, dietary habit, and intake of antioxidants,
such as ascorbic acid (vitamin C) and a-tocopherol
(vitamine E), polyphenol and resveratrol (a red wine
constituent) and pharmacological agents. Finally, the
measurement of TBARS using the method of Yagi [14],
particularly without an HPLC/GCMS clean-up to isolate
Table 3 Longitudinal results of uni- and multi-variate analyses
Correlation between one-year ΔTBARS and Δvalues of various parameters
One-year Δ TBARS Univariate Multivariate1 (eVFA) Multivariate2 (BMI)
R p value F value r p value F value r p value
Δ BMI 0.105 0.0003 - - - 10.389 0.092 0.0013
Δ WC 0.054 0.0634 - - - - - -
Δ eVFA 0.090 0.0020 5.278 0.066 0.0218 - - -
Δ SBP -0.042 0.1480
Δ DBP 0.025 0.3822
Δ HDL-C -0.006 0.8320
Δ LDL-C 0.047 0.1099
Δ HbA1c 0.039 0.1864
Δ adiponectin -0.018 0.5348
Δ g-GTP -0.132 < 0.0001 17.775 -0.121 < 0.0001 17.994 -0.121 < 0.0001
Δ eGFR -0.154 < 0.0001 27.577 -0.150 < 0.0001 28.731 -0.153 < 0.0001
Δ UA 0.086 0.0033 0.001 - - 0.013 - -
Correlation between biennial ΔTBARS and Δvalues of various parameters
Biennial Δ TBARS Univariate Multivariate1 (eVFA) Multivariate2 (BMI)
r p value F value r p value F value r p value
Δ BMI 0.109 0.0002 - - - 10.243 0.093 0.0014
Δ WC 0.091 0.0018 - - - - - -
Δ eVFA 0.094 0.0013 6.433 0.074 0.0113 - - -
Δ SBP -0.040 0.1732
Δ DBP 0.003 0.9147
Δ HDL-C -0.045 0.1222
Δ LDL-C 0.078 0.0077 3.759 - - 3.073 - -
Δ HbA1c 0.008 0.7720
Δ adiponectin -0.020 0.4970
Δ g-GTP -0.103 0.0004 9.627 -0.090 0.0020 9.282 -0.088 0.0024
Δ eGFR -0.115 < 0.0001 14.417 -0.109 0.0002 14.835 -0.111 0.0001
Δ UA 0.084 0.0037 0.285 - - 0.255 - -
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sensitivity and specificity because TBA reacts with a
variety of compounds (sugars, amino acids, bilirubin and
albumin). More specific markers need to be measured
[28].
In conclusion, the absolute value and sequential changes
in systemic oxidative stress correlated significantly with
those of adiposity, especially the amount of visceral fat, g-
GTP, and eGFR, in middle-aged Japanese men.
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